Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Hiking and camping aren’t always the easiest activities for those living with ongoing health issues. But these three women ...

A study has shown how data, collected by wearable technology, can identify disease flare-ups up to seven weeks in advance.

CJ Bioscience announced today that it will present preclinical data on its novel drug candidate CJRB-201 at the European ...

In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...

Young people are more than twice as likely to get forms of bowel cancer than older Australians were at the same age, and ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Step inside Asst. Prof. Sam Light’s lab to learn how scientists are mapping the incredible network of microbes living inside ...

Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.

Australians living with inflammatory bowel disease (IBD) are calling for more support and research amid warnings the often stigmatising condition is costing the economy $7.8 billion a year.

Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million ...